Suppr超能文献

当同种异体H-2单倍型在造血起源的细胞上表达,但不在胸腺上皮细胞上表达时,NOD/Lt骨髓中致糖尿病T细胞的发育受阻。

Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.

作者信息

Serreze D V, Leiter E H

机构信息

Jackson Laboratory, Bar Harbor, ME 04609.

出版信息

J Immunol. 1991 Aug 15;147(4):1222-9.

PMID:1869820
Abstract

Diabetes is a T cell-mediated process in NOD/Lt mice, with a major genetically recessive component of susceptibility linked to homozygous expression of the unique H-2g7 MHC haplotype. Heterozygous expression of the H-2nb1 haplotype derived from the NON/Lt strain confers diabetes resistance both in (NOD x NON)F1 hybrids and in NOD mice congenic for the H-2nb1 haplotype. However, diabetes resistance is abrogated in F1 hybrids by NOD/Lt bone marrow reconstitution. To establish whether the generation of beta cell autoreactive T cells from NOD/Lt bone marrow-derived precursors required at least heterozygous expression of the H-2g7 haplotype on thymic epithelium, adolescent thymectomized (NOD x NON)F1 mice were implanted with neonatal NON/Lt thymus grafts before lethal radiation and reconstitution with NOD/Lt bone marrow. Peripheral T cells maturing through this ectopic thymic implant exclusively expressed the NOD H-2g7 haplotype and were tolerant to H-2nb1 skin grafts. Nevertheless, diabetes developed in 32% of the NON/Lt thymus-grafted chimeras vs 38% of the sham-thymectomized NOD bone marrow chimeras. Thus, homozygous expression of the diabetes-resistant H-2nb1 haplotype on thymic epithelium failed to block development of a diabetogenic T cell repertoire. To examine if expression of H-2nb1 on hemopoietically derived APC could alter the diabetogenic potential of NOD/Lt marrow, diabetes-resistant NOD.NON-H-2nb1 congenic mice were mated with NOD/Lt mice to produce NOD-H-2g7/H-2nb1 heterozygous recipients. These were lethally irradiated and reconstituted with either NOD/Lt marrow alone, NOD.H-2nb1 homozygous congenic marrow alone, or a 1:1 mixture of the two marrow populations. By 25 wk of age, all of the MHC heterozygous recipients of NOD.NON-H-2nb1 marrow remained diabetes-free whereas 75% of the MHC heterozygous recipients of NOD/Lt marrow developed diabetes. A striking decrease in diabetes was observed when T cell precursors derived from NOD/Lt marrow interacted with H-2nb1 gene products on hemopoietically derived APC, inasmuch as only 7% of the MHC heterozygous recipients reconstituted with a 1:1 mixture of NOD/Lt and NOD.NON-H-2nb1 marrow developed diabetes. Peripheral leukocytes in all reconstitution classes expressed the MHC phenotype(s) of the marrow donor(s). Skin grafting confirmed that all reconstitution classes of MHC heterozygous recipients were tolerant to the H-2nb1 haplotype.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在非肥胖糖尿病(NOD)/Lt小鼠中,糖尿病是一个由T细胞介导的过程,其易感性的主要遗传隐性成分与独特的H-2g7 MHC单倍型的纯合表达相关。源自NON/Lt品系的H-2nb1单倍型的杂合表达在(NOD×NON)F1杂种以及H-2nb1单倍型的NOD同源基因小鼠中均赋予糖尿病抗性。然而,通过NOD/Lt骨髓重建,F1杂种中的糖尿病抗性被消除。为了确定从NOD/Lt骨髓来源的前体产生β细胞自身反应性T细胞是否至少需要胸腺上皮细胞上H-2g7单倍型的杂合表达,在致死性照射和用NOD/Lt骨髓重建之前,对青春期胸腺切除的(NOD×NON)F1小鼠植入新生NON/Lt胸腺移植物。通过这种异位胸腺植入成熟的外周T细胞仅表达NOD H-2g7单倍型,并且对H-2nb1皮肤移植物具有耐受性。尽管如此,32%的植入NON/Lt胸腺的嵌合体发生了糖尿病,而假胸腺切除的NOD骨髓嵌合体中这一比例为38%。因此,胸腺上皮细胞上抗糖尿病的H-2nb1单倍型纯合表达未能阻止致糖尿病T细胞库的发育。为了研究造血来源的抗原呈递细胞(APC)上H-2nb1的表达是否可以改变NOD/Lt骨髓的致糖尿病潜力,将抗糖尿病的NOD.NON-H-2nb1同源基因小鼠与NOD/Lt小鼠交配,以产生NOD-H-2g7/H-2nb1杂合受体。这些小鼠接受致死性照射,然后单独用NOD/Lt骨髓、单独用NOD.H-2nb1纯合同源基因骨髓或两种骨髓群体的1:1混合物进行重建。到25周龄时,所有接受NOD.NON-H-2nb1骨髓的MHC杂合受体均未发生糖尿病,而接受NOD/Lt骨髓的MHC杂合受体中有75%发生了糖尿病。当源自NOD/Lt骨髓的T细胞前体与造血来源的APC上的H-2nb1基因产物相互作用时,观察到糖尿病显著减少,因为在用NOD/Lt和NOD.NON-H-2nb1骨髓的1:1混合物重建的MHC杂合受体中,只有7%发生了糖尿病。所有重建组的外周白细胞均表达骨髓供体的MHC表型。皮肤移植证实,所有重建组的MHC杂合受体均对H-2nb1单倍型具有耐受性。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验